Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Product number

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision (3) Apply European Commission final decision filter

Referral type

Article 20 procedures (2) Apply Article 20 procedures filter Article 31 referrals (1) Apply Article 31 referrals filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC Remove PRAC-CHMP-EC filter PRAC-CMDh (5) Apply PRAC-CMDh filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (1) Apply Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) (2) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Suspension Remove Suspension filter No further action (1) Apply No further action filter Risk minimisation measures (18) Apply Risk minimisation measures filter Variation (3) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Decision date

From:

To:

Medicine type

Additional monitoring (1) Apply Additional monitoring filter

Related medicine

Therapeutic area

First published

From:

To:

3 results

Remove all filtersRemove all filters

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Categories Human Remove Human filter

Referral PRAC recommendation Suspension Remove Suspension filter

Referral decision making model PRAC-CHMP-EC Remove PRAC-CHMP-EC filter

Sort by

List item

Referral: Zinbryta

daclizumab, ?> associated names: Zinbryta, Article 20 procedures
Status: European Commission final decision, EC decision date: 27/03/2018,
List item

Referral: Gadolinium-containing contrast agents

gadobenic acid / gadobutrol / gadodiamide / gadopentetic acid / gadoteric acid / gadoteridol / gadoversetamide / gadoxetic acid, ?> associated names: Optimark, Article 31 referrals
Status: European Commission final decision, opinion/position date: 20/07/2017, EC decision date: 23/11/2017,
List item

Referral: Tredaptive, Pelzont and Trevaclyn

laropiprant / nicotinic acid, ?> Article 20 procedures
Status: European Commission final decision, EC decision date: 22/03/2013,

3 results

Referral: Zinbryta

Referral: Gadolinium-containing contrast agents

Referral: Tredaptive, Pelzont and Trevaclyn